We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+8.95%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$2.06B
AUM Growth
+$107M
Cap. Flow
-$28.6M
Cap. Flow %
-1.39%
Top 10 Hldgs %
29.47%
Holding
2,720
New
413
Increased
568
Reduced
616
Closed
259

Sector Composition

Rank Sector Weight
1 Technology 24.3%
2 Healthcare 11.82%
3 Financials 10.45%
4 Consumer Discretionary 9.39%
5 Industrials 7.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NRIM icon
2201
Northrim BanCorp
NRIM
$601M
$12.1K ﹤0.01%
+1,228
New +$12.3K
SCU
2202
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$12K ﹤0.01%
1,364
JBIO
2203
Jade Biosciences
JBIO
$1.51B
$12K ﹤0.01%
20
ITIC
2204
Investors Title Co
ITIC
$534M
$12K ﹤0.01%
82
SPWH icon
2205
Sportsman's Warehouse
SPWH
$46.8M
$12K ﹤0.01%
2,098
+721
+52% +$4.34K
MVBF icon
2206
MVB Financial
MVBF
$397M
$12K ﹤0.01%
567
JANX icon
2207
Janux Therapeutics
JANX
$978M
$11.9K ﹤0.01%
1,004
PRTS icon
2208
CarParts.com
PRTS
$50.3M
$11.9K ﹤0.01%
+280
New +$12.5K
HBT icon
2209
HBT Financial
HBT
$1.35B
$11.9K ﹤0.01%
645
RXT icon
2210
Rackspace Technology
RXT
$1.1B
$11.9K ﹤0.01%
4,359
+1,183
+37% +$1.95K
WVE icon
2211
Wave Life Sciences
WVE
$1.02B
$11.9K ﹤0.01%
+3,256
New +$13.2K
IMRX icon
2212
Immuneering
IMRX
$336M
$11.8K ﹤0.01%
+1,167
New +$11.2K
HBIO icon
2213
Harvard Bioscience
HBIO
$30.4M
$11.8K ﹤0.01%
+216
New +$11.9K
CMAX
2214
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$11.8K ﹤0.01%
127
+67
+112% +$5.9K
ADV icon
2215
Advantage Solutions
ADV
$423M
$11.8K ﹤0.01%
202
+135
+201% +$5.78K
HBCP icon
2216
Home Bancorp
HBCP
$569M
$11.8K ﹤0.01%
355
IBEX icon
2217
IBEX
IBEX
$482M
$11.8K ﹤0.01%
+555
New +$11.9K
PCYO icon
2218
Pure Cycle
PCYO
$273M
$11.8K ﹤0.01%
1,071
+667
+165% +$6.62K
SFST icon
2219
Southern First Bancshares
SFST
$612M
$11.8K ﹤0.01%
476
SRRK icon
2220
Scholar Rock
SRRK
$6.46B
$11.8K ﹤0.01%
+1,562
New +$11.8K
MBCN
2221
DELISTED
Middlefield Banc Corp
MBCN
$11.7K ﹤0.01%
+438
New +$11.4K
ATXS
2222
DELISTED
Astria Therapeutics
ATXS
$11.7K ﹤0.01%
+1,406
New +$16.2K
TREE icon
2223
LendingTree
TREE
$461M
$11.7K ﹤0.01%
528
RSI icon
2224
Rush Street Interactive
RSI
$2.85B
$11.6K ﹤0.01%
3,728
+1,951
+110% +$6.02K
LAW icon
2225
CS Disco
LAW
$297M
$11.6K ﹤0.01%
1,412

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q2 2023 Portfolio in Review

As of Q2 2023, Metropolitan Life Insurance Company (MetLife) held 2,720 positions worth $2.06B, up 5.5% from $1.95B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q2 2023 filing shows 413 new, 568 increased, 616 reduced and 259 closed positions. Its largest new stake was Alphabet (Google) Class C: 222,708 shares worth $26.9M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $16.1M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q2 2023 buy was Alphabet (Google) Class C: 222,708 shares worth $26.9M.
  • Metropolitan Life Insurance Company (MetLife) added most to Vanguard Total Bond Market in Q2 2023, an estimated $15M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $16.1M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Iridium Communications in Q2 2023, selling an estimated $418K.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 29% of its $2.06B portfolio in Q2 2023.
  • Metropolitan Life Insurance Company (MetLife) opened 413 new positions and closed 259 in Q2 2023.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 5.5% quarter-over-quarter to $2.06B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2023, filed 10 Aug 2023.